Skip to main content


  • Erratum
  • Open Access
  • Erratum to: Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer

    Molecular Cancer201211:68

    • Received: 13 August 2012
    • Accepted: 13 August 2012
    • Published:

    The original article was published in Molecular Cancer 2012 11:43


    To further confirm that the inactivation of Lyn inhibited CD24-induced ERK1/2 activation, we submitted the results of another CD24siRNA (CD24siRNA-2) as the Additional file 1: Figure S2. After publication of the article [1] the authors noted that the wrong figure for Additional file 1: Figure S2 was submitted by mistake. The correct image was conducted in SW480CD24 using CD24siRNA-2 (new Additional file 1: attached). The authors apologise for any inconvenience caused.



    Authors’ Affiliations

    Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China
    Guangdong Provincial key laboratory of Gastroenterology, Guangzhou, 510515, China
    Huizhou Medical Institute, Huizhou, Guangdong, 516001, China


    1. Su N, Peng L, Xia B, Zhao Y, Xu A, Wang J, Wang X, Jiang B: Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer. Mol Cancer. 2012, 11: 43- 10.1186/1476-4598-11-43PubMed CentralView ArticlePubMedGoogle Scholar


    © Su et al.; licensee BioMed Central Ltd. 2012

    This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.